Literature DB >> 18272668

HLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease.

Najat Mahdi1, Khadija Al-Ola, Abeer M Al-Subaie, Muhallab E Ali, Zaid Al-Irhayim, A Qader Al-Irhayim, Wassim Y Almawi.   

Abstract

We investigated the association of HLA class II alleles and haplotypes with sickle cell anemia vaso-occlusive crisis (VOC). DRB1*100101 was positively associated, while DRB1*140101, DRB1*150101, and DQB1*060101 were negatively associated, with VOC. Both susceptible (DRB1*100101-DQB1*050101) and protective (DRB1*110101-DQB1*030101 and DRB1*150101-DQB1*060101) haplotypes were identified, indicating that HLA class II haplotypes influence VOC risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272668      PMCID: PMC2292664          DOI: 10.1128/CVI.00425-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

Review 1.  Sickle cell disease: a multigenic perspective of a single gene disorder.

Authors:  Abdullah Kutlar
Journal:  Hematology       Date:  2005       Impact factor: 2.269

2.  Evidence for HLA-related susceptibility for stroke in children with sickle cell disease.

Authors:  L A Styles; C Hoppe; W Klitz; E Vichinsky; B Lubin; E Trachtenberg
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Authors:  A M Mohammad; K O Ardatl; K M Bajakian
Journal:  J Trop Pediatr       Date:  1998-04       Impact factor: 1.165

4.  HLA-DRB1 alleles in Hb SS patients with avascular necrosis of the femoral head.

Authors:  A Adekile; M Z Haider; R Marouf; A D Adekile
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

Review 5.  Pain management in children with sickle cell disease.

Authors:  Jennifer Stinson; Basem Naser
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.

Authors:  Fayza A Al-Jenaidi; Saria F Wakim-Ghorayeb; Abduljabbar Al-Abbasi; Mona R Arekat; Noha Irani-Hakime; Pierre Najm; Khadija Al-Ola; Ayesha A Motala; Wassim Y Almawi
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

7.  Impaired vasodilation by red blood cells in sickle cell disease.

Authors:  John R Pawloski; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

8.  Distinct HLA associations by stroke subtype in children with sickle cell anemia.

Authors:  Carolyn Hoppe; William Klitz; Janelle Noble; Lara Vigil; Elliott Vichinsky; Lori Styles
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

9.  Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.

Authors:  A M Mohammed; F Al-Hilli; K V Nadkarni; G P Bhagwat; J P Bapat
Journal:  Ann Saudi Med       Date:  1992-11       Impact factor: 1.526

Review 10.  Hypercoagulability in sickle cell disease: a curious paradox.

Authors:  Kenneth I Ataga; Eugene P Orringer
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.